Antibiotics are given to food animals for many reasons, such as for infectious diseasetreatment and control, and for disease prevention before a herd- or flock-wideoutbreak of disease occurs. During the 1950s, antimicrobial use for growth promotionwas widely advocated. The practice enhanced the feed-to-weight ratio for poultry,swine and beef cattle. This buoyed the economic incentive for using subtherapeuticquantities of the antibiotics tetracycline and penicillin in dosages from a tenth to ahundredth of a therapeutic dose, and the use of antibiotics in food animal productionfor feed efficiency took root.A Tale of Two AntibioticsIn August 1977, the U.S. <strong>Food</strong> and Drug Administration (FDA) examined new evidenceshowing that subtherapeutic use is not safe for humans, and FDA proposed towithdraw approval for all use of penicillin in animal feed. That same year in October,evidence surfaced that subtherapeutic use“The emergence ofantibiotic-resistantfoodborne pathogens isinherently linked to howantibiotics have beenused in food animalproduction.”of tetracycline in animal feed is not safefor humans, and FDA proposed to withdrawits approval as well.Much of this thinking may have beensparked by a study published in the NewEngland Journal of Medicine by Levy et al. in1976: “Changes in the intestinal flora offarm personnel after introduction of atetracycline-supplemented food on afarm.” 3 This study tested isolates fromchickens and people on a farm and foundlow initial levels of tetracycline-resistant intestinalbacteria. As expected under thepremise of selective pressure, within 2weeks after the chickens were fed tetracycline-supplementedfeed, 90 percent of thechickens were excreting tetracycline-resistantbacteria. Yet the problem wasn’t isolated to tetracycline; many of the bacteria developedresistance to four antibiotics despite their exposure to tetracycline only.Within 6 months of the administration of tetracycline-spiked feed to chickens, a majorityof the people from the farm were excreting antibiotic-resistant bacteria as well.Significantly, when these same persons were tested 6 months after the tetracycline-supplementedfeed was discontinued, no detectable tetracycline-resistant organisms werefound in the majority of the farm participants. This study showed that the resistantbacteria contained transferable plasmids that conferred multiple antibiotic resistances,not just resistance to tetracycline. The evolutionary pressure imposed by the tetracycline-supplementedfeed for multiple drug resistance in chickens extended to humansin contact with the chickens and the feed, but luckily not in statistically significantamounts to their neighbors. (Comparatively, 7 of 11 farm residents compared withonly 3 of 24 neighbors, p < 0.01, during the 5- to 6-month feeding period showedfecal samples with greater than 80% tetracycline-resistant coliforms.)The 1977 Bureau of Veterinary Medicine (today’s equivalent of the Center for VeterinaryMedicine—CVM—of FDA) concluded that growth-promotion uses of penicillinand tetracycline (two human medicines) in animal agriculture cause theemergence of resistant strains of bacteria, which can move from agriculture onto thedinner plates of the American public through contaminated food, and thus threatenthe health of the general population. For those reasons, they sought, through two Noticesof Opportunity for a Hearing (NOOH) published in the Federal Register, to revokeapprovals for penicillin and tetracycline. 4 This serves to underline the fact thatFDA has consistently believed, for several decades now, that there are human healthrisks in using subtherapeutic doses of medically important antibiotics in animalagriculture.Let’s now jump to December 22,2011, when FDA withdrew the two 1977NOOHs to reverse its approval to administerpenicillin and tetracycline infeed. 5 Instead, FDA stated that they areclosing the dockets because they are engagingin other ongoing regulatorystrategies developed since the publicationof the 1977 NOOHs to address microbialfood safety issues.Although not explicitly stated, thisleads one to the conclusion that FDA isturning to the food animal agriculturalindustry to enforce judicious use itself,and asking that forthcoming voluntaryguidance 209 and its companion document213 be followed.The FDA states in its recent decisionthat it “intends to focus its efforts fornow on the potential for voluntary reformand the promotion of the judicioususe of antimicrobials in the interest ofpublic health. Importantly, this strategyleaves open the possibility of pursuingwithdrawal proceedings at a later time ifFDA’s proposed strategy does not yieldsatisfactory results.” 5Reading Tea LeavesSo what does the future look like?Based on the timeline provided (see “ATimeline of Antibiotic Regulation,” p.40), anything is possible. What can be ascertainedis that using medically importantantimicrobial drugs to increaseproduction in food animals is not consideredby FDA to be judicious use.Guidance 209 has not been formally issued.However, according to 209, theDraft Guidance “The Judicious Use ofMedically Important AntimicrobialDrugs in <strong>Food</strong>-Producing Animals” givesvast insight into what can be expected.FDA defines judicious use as “using an antimicrobialdrug only when necessaryand appropriate.” The effects of medicallyimportant antibiotics used asgrowth promoters in food animals andtheir effects on increasing antibiotic resistanceare clear, and FDA makes somestrong statements in the guidance draftto tackle this practice.“Antimicrobial drugs that are importantfor treating infectious diseases inpeople, particularly infections caused bybacteria” are considered the working def-38 F O O D S A F E T Y M A G A Z I N E
For the first time, a vaccine can help reduce the prevalence and shedding of Escherichia coli (E. coli) O157much earlier in the chain — in the cattle — creating a way for cattle producers and veterinarians to team upwith packers, retailers and consumers. Escherichia Coli Bacterial Extract vaccine* with SRP ® technology, used atthe feedlot, has been shown to reduce the number of cattle entering the plant with E. coli O157 by 85 percent. 1Less E. coli O157 entering the plant enhances your efforts to help eliminate foodborne pathogens. To learnmore, visit www.SRPEcoli.com.Together, we can reduce E.coli O157.*This product license is conditional. Efficacy and potency test studies are in progress.1Thomson DU, Loneragan GH, Thornton AB, Lechtenberg KF, Emery DA, Burkhardt DT, Nagaraja TG. Use of a siderophore receptor and porin proteins-based vaccineto control the burden of Escherichia coli O157:H7 in feedlot cattle. <strong>Food</strong>borne Pathogens and Disease. 2009;6:871-877.All brands are the property of their respective owners. ©2011 Pfizer Inc. All rights reserved. SRP11028
- Page 6 and 7: Editor’s LetterAntibiotic Resista
- Page 8 and 9: News BitesFDA Sued Over Nanotechnol
- Page 10 and 11: 7Entende-se, no entanto, que há ob
- Page 14 and 15: TESTINGsites for Listeria growth, t
- Page 16: REGULATORY REPORTBy Markus Lipp, Ph
- Page 19 and 20: REGULATORY REPORTIn a globalized fo
- Page 21 and 22: INTERNATIONAL FOOD SAFETYbe to haul
- Page 24 and 25: PACKAGINGto commercial sterility) o
- Page 26 and 27: PACKAGINGfor sale, and income to bu
- Page 28 and 29: WELCOMEWHO ATTENDS THE SUMMITSoluti
- Page 30: Providing the highestquality educat
- Page 34 and 35: ®®EXHIBITOR SHOWCASETHEATRESThe E
- Page 38 and 39: CONFERENCE SESSIONS THURSDAY, APRIL
- Page 40 and 41: EXHIBITION HALLWhere Solutions Are
- Page 42 and 43: 155 N. Pfingsten Rd., Suite 205Deer
- Page 44: FOOD SAFETY INSIDERNovel Developmen
- Page 47 and 48: Chris CelustaFood Processing Manage
- Page 49 and 50: Discover a million reasonsTotal Pla
- Page 51 and 52: control yourWOrLdwith LIGHTNING MVP
- Page 53: community, which is heralding more
- Page 57 and 58: What GFI 152 has done is pave thewa
- Page 59 and 60: major species to treat or control a
- Page 61 and 62: Friday, October 21, 1977).5. Federa
- Page 63 and 64: Complex threatsA simple sandwich re
- Page 65 and 66: SPOTLIGHT: MEAT AND POULTRYUnlike r
- Page 67 and 68: Solutions for TodayPlanning for Tom
- Page 69 and 70: CATEGORY: INGREDIENTScolors. Howeve
- Page 71 and 72: MORESAFETY. RESEARCH. TRENDS.MANAGE
- Page 73 and 74: MICROBIOLOGYtial sources can be det
- Page 75 and 76: MICROBIOLOGYficient to adequately c
- Page 77 and 78: MICROBIOLOGYProcess step or areaLik
- Page 79 and 80: Sample Prep InstrumentInnovaPrep LL
- Page 81 and 82: SPOTLIGHT: MEAT AND POULTRY(continu
- Page 83 and 84: Advertisers IndexAdvanced Instrumen